Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1977 1
1978 1
1980 2
1981 1
1982 2
1983 2
1984 5
1985 6
1986 4
1987 7
1988 9
1989 5
1990 12
1991 9
1992 5
1993 12
1994 11
1995 17
1996 13
1997 8
1998 8
1999 10
2000 12
2001 15
2002 28
2003 27
2004 28
2005 51
2006 43
2007 57
2008 70
2009 63
2010 77
2011 73
2012 105
2013 100
2014 97
2015 98
2016 76
2017 93
2018 108
2019 113
2020 127
2021 156
2022 142
2023 108
2024 151
2025 121
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,100 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer.
Uppaluri R, Haddad RI, Tao Y, Le Tourneau C, Lee NY, Westra W, Chernock R, Tahara M, Harrington KJ, Klochikhin AL, Braña I, Vasconcelos Alves G, Hughes BGM, Oliva M, Pinto Figueiredo Lima I, Ueda T, Rutkowski T, Schroeder U, Mauz PS, Fuereder T, Laban S, Oridate N, Popovtzer A, Mach N, Korobko Y, Costa DA, Hooda-Nehra A, Rodriguez CP, Bell RB, Manschot C, Benjamin K, Gumuscu B, Adkins D; KEYNOTE-689 Investigators. Uppaluri R, et al. N Engl J Med. 2025 Jul 3;393(1):37-50. doi: 10.1056/NEJMoa2415434. Epub 2025 Jun 18. N Engl J Med. 2025. PMID: 40532178 Clinical Trial.
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study.
Sun JM, Shen L, Shah MA, Enzinger P, Adenis A, Doi T, Kojima T, Metges JP, Li Z, Kim SB, Cho BC, Mansoor W, Li SH, Sunpaweravong P, Maqueda MA, Goekkurt E, Hara H, Antunes L, Fountzilas C, Tsuji A, Oliden VC, Liu Q, Shah S, Bhagia P, Kato K; KEYNOTE-590 Investigators. Sun JM, et al. Among authors: li sh. Lancet. 2021 Aug 28;398(10302):759-771. doi: 10.1016/S0140-6736(21)01234-4. Lancet. 2021. PMID: 34454674 Clinical Trial.
Cell and transcriptomic diversity of infrapatellar fat pad during knee osteoarthritis.
Peters H, Potla P, Rockel JS, Tockovska T, Pastrello C, Jurisica I, Delos Santos K, Vohra S, Fine N, Lively S, Perry K, Looby N, Li SH, Chandran V, Hueniken K, Kaur P, Perruccio AV, Mahomed NN, Rampersaud R, Syed K, Gracey E, Krawetz R, Buechler MB, Gandhi R, Kapoor M. Peters H, et al. Among authors: li sh. Ann Rheum Dis. 2025 Feb;84(2):351-367. doi: 10.1136/ard-2024-225928. Epub 2025 Jan 2. Ann Rheum Dis. 2025. PMID: 39919907 Free article.
Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study.
Li SH, Mei J, Cheng Y, Li Q, Wang QX, Fang CK, Lei QC, Huang HK, Cao MR, Luo R, Deng JD, Jiang YC, Zhao RC, Lu LH, Zou JW, Deng M, Lin WP, Guan RG, Wen YH, Li JB, Zheng L, Guo ZX, Ling YH, Chen HW, Zhong C, Wei W, Guo RP. Li SH, et al. J Clin Oncol. 2023 Apr 1;41(10):1898-1908. doi: 10.1200/JCO.22.01142. Epub 2022 Dec 16. J Clin Oncol. 2023. PMID: 36525610 Free PMC article. Clinical Trial.
Targeting vulnerable microcircuits in the ventral hippocampus of male transgenic mice to rescue Alzheimer-like social memory loss.
Lei HY, Pi GL, He T, Xiong R, Lv JR, Liu JL, Wu DQ, Li MZ, Shi K, Li SH, Yu NN, Gao Y, Yu HL, Wei LY, Wang X, Zhou QZ, Zou PL, Zhou JY, Liu YZ, Shen NT, Yang J, Ke D, Wang Q, Liu GP, Yang XF, Wang JZ, Yang Y. Lei HY, et al. Among authors: li sh. Mil Med Res. 2024 Mar 11;11(1):16. doi: 10.1186/s40779-024-00512-z. Mil Med Res. 2024. PMID: 38462603 Free PMC article.
Male-Biased Gut Microbiome and Metabolites Aggravate Colorectal Cancer Development.
Wang L, Tu YX, Chen L, Zhang Y, Pan XL, Yang SQ, Zhang SJ, Li SH, Yu KC, Song S, Xu HL, Yin ZC, Yue JQ, Ni QL, Tang T, Zhang JL, Guo M, Zhang S, Yao F, Liang XJ, Chen ZX. Wang L, et al. Among authors: li sh. Adv Sci (Weinh). 2023 Sep;10(25):e2206238. doi: 10.1002/advs.202206238. Epub 2023 Jul 3. Adv Sci (Weinh). 2023. PMID: 37400423 Free PMC article.
Applications of nanomaterials in COVID-19 pandemic.
Xiao MF, Zeng C, Li SH, Yuan FL. Xiao MF, et al. Among authors: li sh. Rare Metals. 2022;41(1):1-13. doi: 10.1007/s12598-021-01789-y. Epub 2021 Sep 15. Rare Metals. 2022. PMID: 34539132 Free PMC article. Review.
2,100 results